OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Detalles Bibliográficos
Autores principales: Salmon-Céron, D, Durier, C, Desaint, C, Cuzin, Surenaud, M, Hénin, Y, Lelièvre, J, Bonnet, B, Pialoux, G, Poizot-Martin, I, Ben Hamouda, N, Jackson, A, Flys, C, Guérin, C, Aboulker, J, Choppin, J, Launay, O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767546/
http://dx.doi.org/10.1186/1742-4690-6-S3-O25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767546/
http://dx.doi.org/10.1186/1742-4690-6-S3-O25

Ejemplares similares